Sabinsa Studies On Gugulipid®

1. Open Field Study to Evaluate  GugulipidÒ in the Treatment of Dyslipidemias - Department of Veterans Affairs Medical Center (Arizona)

The purpose of this study is to investigate the effect of GugulipidÒ on serum lipids (i.e. cholesterol, LDL, HDL, triglycerides) in individuals with dyslipidemias. All individuals are volunteers who have serum cholesterol levels > 200 mg/dL. Serum cholesterol levels and the levels of other parameters are measured prior to and after treatment with GugulipidÒ.

2. IND Study #59, 172 - Randomized, Double-Blind,   Placebo-Controlled Trial Evaluating the Safety and  Efficacy of GugulipidÒ in Americans with Hypercholesterolemia - University of Pennsylvania.

The purpose of this study is to evaluate the efficacy and safety of GugulipidÒ in Americans with dyslipidemias. The participants of the study are volunteers, 18 years and older, who have LDL levels between 130-190 mg/dL and triglycerides less than 400 mg/dL. The safety of the study will be measured by self-reported adverse events. In addition hematological and blood biochemistry parameters will be assessed throughout the study to monitor safety and efficacy. The efficacy of GugulipidÒ will be measured as a percent change from baseline in total cholesterol, LDL, HDL, and triglycerides in GugulipidÒ versus placebo groups.

"These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, cure, or prevent any disease"
 

Copyright © Sabinsa Corporation. All Rights Reserved | Disclaimer

Disclaimer
×

US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.